ARKK vs XBI
ARK Innovation ETF vs SPDR S&P Biotech ETF
ARKK$77.93
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
XBI$133.66
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.34%
Quick take
- • XBI has the lower expense ratio at 0.35% vs 0.75% for ARKK.
- • XBI pays a higher dividend yield (0.34%).
Side-by-side metrics
| Metric | ARKK | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $6.48B | $8.30B |
YTD return | 3.46% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.36 | 1.09 |
P/E ratio | 46.69 | — |
Last price | $77.93 | $133.66 |
Inception | — | — |
Issuer | ARK | State Street |
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 9.73% |
| TEM | Tempus AI Inc Class A common stock | 5.35% |
| AMD | Advanced Micro Devices Inc | 5.18% |
| CRSP | CRISPR Therapeutics AG | 4.98% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.37% |
| ROKU | Roku Inc Class A | 4.33% |
| HOOD | Robinhood Markets Inc Class A | 4.30% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 4.23% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 3.84% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 3.13% |
Sector breakdown · ARKK
Consumer Cyclical13.7%
Technology26.4%
Communication Services10.9%
Financial Services15.4%
Industrials6.3%
Healthcare27.5%
XBI top holdings
Top holdings · XBI
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
Sector breakdown · XBI
Financial Services0.2%
Healthcare99.8%
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.5B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 9.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.7%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.